Evidence map›Paper›PMID 37211090›Full record

ArticleAmerican journal of obstetrics & gynecology MFM2023

A comparison of postpartum opioid consumption and opioid discharge prescriptions among opioid-naïve patients and those with opioid use disorder.

Erica Holland, Liza Gibbs, Nicole Z Spence, Monica Young, Martha M Werler, Zeyu Guang, Kelley Saia, Brian T Bateman, Rachel Achu, Elisha M Wachman

Registry-linked trialAbstract read
In one paragraph

Article in American journal of obstetrics & gynecology MFM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06784180 (Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06784180 phase4withdrawnnot on this mapstarted 2026, after this paper: background citation

Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2026 to 2029Enrolled0ConditionsOpioid Use DisorderArmsMorphine, Bupivacaine, Fentanyl, Hydromorphone
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Erica HollandDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA (Dr Holland, Ms Young, and Dr Saia). Electronic address: erica.holland@bmc.org.
Liza GibbsDepartment of Epidemiology, Boston University School of Public Health, Boston, MA; Scientific Research and Strategy, Aetion, Inc, Boston, MA (Mses Gibbs and Guang).
Nicole Z SpenceDepartment of Anesthesiology, Boston Medical Center, Boston University School of Medicine, Boston, MA (Drs Spence and Achu).
Monica YoungDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA (Dr Holland, Ms Young, and Dr Saia).
Martha M WerlerDepartment of Epidemiology, Boston University School of Public Health, Boston, MA (Dr Werler).
Zeyu GuangDepartment of Epidemiology, Boston University School of Public Health, Boston, MA; Scientific Research and Strategy, Aetion, Inc, Boston, MA (Mses Gibbs and Guang).
Kelley SaiaDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA (Dr Holland, Ms Young, and Dr Saia).
Brian T BatemanDepartment of Anesthesiology, Perioperative and Pain Medicine (Dr Bateman) and Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA (Dr Bateman).
Rachel AchuDepartment of Anesthesiology, Boston Medical Center, Boston University School of Medicine, Boston, MA (Drs Spence and Achu).
Elisha M WachmanDivision of Newborn Medicine, Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA (Dr Wachman).
Boston University · USStanford University · US

Funding

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorderR01HD096798 · NICHD · BOSTON MEDICAL CENTER · PI WACHMAN, ELISHA · 2018 to 2022
$3.4M
NICHD NIH HHS R01 HD096798
6 · The paper itself

Abstract

backgroundManagement of patients with opioid use disorder during the acute postpartum period remains clinically challenging as obstetricians aim to mitigate postdelivery pain while optimizing recovery support.

objectiveThis study aimed to evaluate postpartum opioid consumption and opioids prescribed at discharge among patients with opioid use disorder treated with methadone, buprenorphine, and no medication for opioid use disorder, as compared with opioid-naïve counterparts. STUDY

designWe conducted a retrospective cohort study of pregnant patients who underwent delivery at >20 weeks' gestation at a tertiary academic hospital between May 2014 and April 2020. The primary outcome of this analysis was the mean daily quantity of oral opioids consumed after delivery while inpatient, in milligrams of morphine equivalents. Secondary outcomes included the following: (1) quantity of oral opioids prescribed at discharge, and (2) prescription for oral opioids in the 6 weeks after hospital discharge. Multiple linear regression was used to compare differences in the primary outcome.

resultsA total of 16,140 pregnancies were included. Patients with opioid use disorder (n=553) consumed 14 milligrams of morphine equivalents per day greater quantities of opioids postpartum than opioid-naïve women (n=15,587), (95% confidence interval, 11-17). Patients with opioid use disorder undergoing cesarean delivery consumed 30 milligrams of morphine equivalents per day greater quantities of opioids than opioid-naïve counterparts (95% confidence interval, 26-35). Among patients who underwent vaginal delivery, there was no difference in opioid consumption among patients with and without opioid use disorder. Compared with patients prescribed methadone, patients prescribed buprenorphine, and those prescribed no medication for opioid use disorder consumed similar opioid quantities postpartum following both vaginal and cesarean delivery. Among patients undergoing cesarean delivery, opioid-naïve patients were more likely to receive a discharge prescription for opioids than patients with opioid use disorder (77% vs 68%; P=.002), despite lower pain scores and less inhospital opioid consumption.

conclusionPatients with opioid use disorder, regardless of treatment with methadone, buprenorphine, or no medication for opioid use disorder consumed significantly greater quantities of opioids after cesarean delivery but received fewer opioid prescriptions at discharge.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidDrug PrescriptionsFemaleHumansMethadoneMorphine DerivativesPatient DischargePostoperative PainPostpartum PeriodPregnancyRetrospective StudiesAnalgesics, OpioidBuprenorphineMethadoneMorphine Derivativesbuprenorphinemethadoneopioid prescriptionopioid use disorderpostpartum pain

Identifiers

PMID37211090
PMCPMC13282841
OpenAlexW4377090426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.